Publication | Open Access

Discovery and characterization of the covalent SARS-CoV-2 3CLpro inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches

Ginkgo Biloba ExtractBiochemistryMedicineCovalent Sars-cov-2 3ClproAntiviral Drug DevelopmentPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyAntiviral CompoundBiochemical ApproachesDrug Discovery